Publication: Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage
Issued Date
2018-10-01
Resource Type
ISSN
15524604
00912700
00912700
Other identifier(s)
2-s2.0-85053676996
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Pharmacology. Vol.58, (2018), S123-S139
Suggested Citation
Paul Ndaya-Oloo, Punnee Pitisuttithum, Nadia G. Tornieporth, Daniel Desgrandchamps, Flor M. Munoz, Sonali Kochhar, Jim Buttery, Jorgen Bauwens, Jan Bonhoeffer Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage. Journal of Clinical Pharmacology. Vol.58, (2018), S123-S139. doi:10.1002/jcph.1140 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46310
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage
Other Contributor(s)
Erasmus University Medical Center
Hochschule Hannover
Monash University
University of Washington, Seattle
Mahidol University
Murdoch Children's Research Institute
Universitäts-Kinderspital beider Basel
Kinderspital Zürich
Baylor College of Medicine
St. Luke Medical Centre
Monash Children's Hospital
Brighton Collaboration Foundation
Global Healthcare Consulting
Hochschule Hannover
Monash University
University of Washington, Seattle
Mahidol University
Murdoch Children's Research Institute
Universitäts-Kinderspital beider Basel
Kinderspital Zürich
Baylor College of Medicine
St. Luke Medical Centre
Monash Children's Hospital
Brighton Collaboration Foundation
Global Healthcare Consulting
Abstract
© 2018, The American College of Clinical Pharmacology Vaccines are increasingly based on new constructs, new technologies, and new compounds. Novel immunization programs are rapidly implemented globally. In this article, we highlight selected hot topics of this highly dynamic and broad field of scientific and public health development. The first section focuses on novel vaccines including malaria, dengue, serogroup B meningococcal, and respiratory syncytial virus vaccines and antibodies. The second section is addressing emerging strategies and programmatic challenges including maternal immunization, integrated mother-child safety monitoring, and finally coping strategies with vaccine shortages.